Completed OBSERVATIONAL NCT04210830

Comparison Two Point of Care Coagulation Monitoring Systems - the ROTEM Sigma and the Quantra Devic

Comparison of Methods for Coagulation Analysis Between Rotem Sigma (Instrumentation Laboratory, Bedfort, MA, USA) and Quantra System (Hemosonics, Charlottesville, VA USA) in Cardiac Surgery

Sponsor: Klinik Hirslanden, Zurich

Conditions Non Inferiority of the Quantra Device

Interventions Quantra-Device

Updated 7 times since 2020 Last updated: Dec 20, 2019 Started: Nov 1, 2018 Primary completion: Oct 3, 2019 Completion: Oct 3, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Non Inferiority of the Quantra Device and is currently completed. Klinik Hirslanden, Zurich leads this study, which shows 7 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed

▶ Show 2 earlier versions

Nov 2020 — Jan 2021 [monthly]

Completed
Jan 2020 — Nov 2020 [monthly]

Completed

First recorded

Nov 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Klinik Hirslanden, Zurich

Data source: Klinik Hirslanden, Zurich

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zurich, Switzerland